Patients with this condition, also known as Gunther’s disease, have reduction-of-function mutations in uroporphyrinogen III synthase (UROS), the 4th enzyme in heme biosynthesis, and consequently produce high levels of porphyrins in their erythroid cells (Discussion). This evidence concerns the gene UROS and cutaneous porphyria.